Sharon Mates is a pharmaceutical executive and scientist who leads Intra-Cellular Therapies, a biopharmaceutical company focused on central nervous system.
Dr. Sharon Mates is a pharmaceutical executive and scientist who leads Intra-Cellular Therapies, a biopharmaceutical company focused on central nervous system disorders. She was instrumental in the company's success, including projecting sales for Caplyta and overseeing a provisional $14 billion sale of Intra-Cellular Therapies to Johnson & Johnson. Mates was also appointed to the Board of Directors of Benitec Biopharma.
Full founder directory · Investor directory · Company funding database · Fundraising library